NASDAQ · UPC
Healthcare · Drug Manufacturers - Specialty & Generic
$1.49
Up+$0.01 (+0.67%)
Updated Nov 4, 2026, 7:25 PM
SID Score
2.2/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance · UPC
1M range · 0 trading sessions · Daily adjusted prices
UPC does not have enough price history for the selected period.
Data unavailable
Market data is busy. Please try again shortly.
The latest Smart Investors Daily articles mentioning UPC.
Company
Market Activity
Research & News
UPC research
Company profile and research snapshot.
Universe Pharmaceuticals Inc is a pharmaceutical company specializing in the manufacturing, marketing, sales and distribution of traditional Chinese medicine derivatives products targeting the elderly with the goal of addressing their physical conditions in the ageing process and promoting their general well-being. The company also sells biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces, and dietary supplements manufactured by third-party pharmaceutical companies. Its products are under two categories namely treatment and relief for common chronic health conditions in the elderly designed to achieve physical wellness and longevity (Chronic Condition Treatments), and cold and flu medications.
Visit company websiteConsensus and target data currently published for this company.
No generated briefing is available yet.
Benzinga · Sep 29, 2026
Gainers Evogene (NASDAQ:EVGN) shares increased by 75.0% to $0.72 during Tuesday's after-market session. The company's market cap stands at $4.5 million. AIxCrypto Hldgs (NASDAQ:AIXC) stock moved upwards by
Benzinga · Sep 29, 2026
https://www.sec.gov/Archives/edgar/data/1809616/000121390026104659/ea0306760-f3_universe.htm
Benzinga · Sep 21, 2026
Gainers Milestone Scientific (AMEX:MLSS) stock moved upwards by 11.8% to $0.44 during Monday's after-market session. The company's market cap stands at $36.9 million. Evotec (NASDAQ:EVO) stock rose 8.44% to
Yahoo · Sep 2, 2026
Universe Pharmaceuticals Inc (NASDAQ:UPC) shares rose 22. 6% to $5.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning UPC.
No results
No recent SID articles mention UPC.
